Member Info for Odysseus07

Skinbiotherapeutics. Up another 30% today. Odd how that good news on trials means sharp rise in SP. And FUM with good news of trials and APPROVAL days away, refuses to budge. As I say, not all shares are as generous as FUM!

Climb aboard! The FUM ship has very generously again turned back from its (very long) trip to Fantasy Island and is back at Reality Dock. How generous can FUM get??? yet another buying opportunity ! So many since 2019. And remember "days away" - by end of February, people are saying £1. And Feb is "definitely the month". Climb aboard.... this time....this time... when we leave Reality Dock it will be non stop high speed to Fantasy Island. Get the ****tails on ice! :)

YoYo. This is the problem. You dont know what you are talking about. Patents normally last 15 years. Can sometimes be extended (if label extension or similar). Viagra patent expired last year. Good grief. Pfizer now make lots of money on the R&D pipeline. successful companies do not wait until products go generic. They have a detailed R&D pipeline and that is what affects their share price.

lol bucolic. I havent my expert scientific knowledge since about Nov.

Listen, good luck bucolic. You obviously need this share to do well and you have invested with lack of understanding of the product and approval status. Good luck, honestly, sounds like you need it to come off. There is a chance.

You have never responded bucolic. Im sorry you are invested so heavily and now sounding worried and desperate

NDR50. That responds to none of the points i made. Also, you have made a basic and common mistake. As FUM have said. Please understand this. Med3000 is not a treatment. It is a device. Just like the CSD500 condoms. It is a device as it contains no active ingredient. The active ingredient (Med2005 - GTN dissolved in solvent was shown to be no more effective than Med3000 - just solvent). And the activve ingredient (GTN) was what was used in the condoms (1%dose)

I'm afraid if you make that simple mistake at the start of your post, then I cant take your opinion seriously.

No bucolic. read my post. I said doing that bit of research, I now think that I wont be investing any more. I think it's a dud. I note you made no contribution to the points I raised. If you disagree, fine. Tell us, rationally, why. What are your responses to my research points?

Just checked. yes futura eventually sold condoms with GTN (the active ingredient that was in med2005). This was CSD500 product. Also launched as a device, not rx, as GTN was only 1% (we now know that GTN is no better than inactive solvent, so GTN being present was irrelevant and it was the "erectogenic" gel by itself that gave any effect - sounds like placebo with condoms to me - mentally believing your erection is being helped).

GTN is the product (med2005) that didnt show any better performance than med3000 (solvent without GTN active substance). CSD500 did increase erection maintenance in trials. But as i say, sales are about £35k a year,.,..... after about 3 years or so being on market.

Now, GTN "failed" in the Deceember 2019 trial (med2005). Leaving med3000 as the only ED product - solvent without GTN. So.... how is this different to the condoms that were launched and failed to sell? Maybe a different solvent (but both are "erectogenic")... but thats irrelevant as the solvents/gels are both not active and as i say the CDM 500 condoms with GTN active ingredient did work in trials (maintaining erection) and were approved as devices. But no sales. So i cant see how a solvent without active ingredient, will sell multiples of 10 times more than £35k.

If you disagree, explain why. I think i just talked myself out of investing here. Think it's a dud.

link here to FUM website, https://www.futuramedical.com/what-we-do/other-products/csd500/csd500/

I invested, as I have said, when FUM was about to launch condoms lubricated with (I believe) what became the active ingredient of med2005. These were, after about 5 years, launched as medical device. Much delayed due to technical issues. They performed well in trials. But FUM said that lack of marketing meant they never achieved expected sales. In fact the revenue is almost nothing (literally £35k a year according to last report).Now, im not saying this is relevant to med300 - this is the solvent only, without the active ingredient. But the condoms above didnt sell well and I think they had some of the active ingredient dissolved as lubricant. I think, cant quite remember. But it shows that its not a given that an approved ED treatment or device will make "millions".

I invested, as I have said, when FUM was about to launch condoms lubricated with (I believe) what became the active ingredient of med2005. These were, after about 5 years, launched as medical device. Much delayed due to technical issues. They performed well in trials. But FUM said that lack of marketing meant they never achieved expected sales. In fact the revenue is almost nothing (literally £35k a year according to last report).Now, im not saying this is relevant to med300 - this is the solvent only, without the active ingredient. But the condoms above didnt sell well and I think they had some of the active ingredient dissolved as lubricant. I think, cant quite remember. But it shows that its not a given that an approved ED treatment or device will make "millions".

i am trying not to think that if i had put £5k into Tesla at start of 2020, would now be selling at £35k...... :( and reading about all the Tesla millionaires.... with hindsight this looked a good punt.... Just didnt think at start of 2020

My punt on skin biotherapeutics is going well. up about 30%. Im contemplating a very risky punt on Thermogenesis Holdings. Makes support equipment for CAR-T. A new form of oncology treatment (you basically extract T-cells from patient, modify them, put them back in patient and the modify T-cells attack cancer cells). This technology (and similar) should grow. The company is at $2 a share... so am tempted, but 3 or so years ago it was $50.... so something went wrong somewhere... it's been tipped by some sites though (and Motley Fool). May be worth a fun punt....

sorry all, couldnt resist. I do think this will go back down to 14p. There will be no partner news by feb. EMEA will give first feedback in Feb. I think there will be questions and re-submission of of some data needed. Then in Feb the FDA trial starts. And In feb/March, FUM will announce some cash raising scheme (probably share offer to investors at lower SP than you can buy on open market). This will dilute the shares to about 10-12p and then I will take a punt with some money

FUM will be low 20s end of w/c 4th Jan. There is just so much positive news around for the company and the rampers have so much rational evidence. FACT.

lol Italian. I wasn't classically educated. But i have been self taught on the classics. hence the name I guess. love Odysseus and Sisyphus. Have a good NYE. We will have dinner, and a glass or two of Veuve Clicquot. Yourself?

By the way, it appears FUM has completed its dark days sailing across the Styx and is now through Hades and Tartarus and is sailing into blessed Elysium.... lol ;)

Hi Italian. Yes, typo (typographical error). Meant rational. Also, did another typo "it's" when meant possessive "its" not abbreviation, "it's". I think and type fast. And spend my time being good at my job and doing decent analysis of stocks that interest me. Hey ho, back to the day job on Tuesday :)
But I know grammar/syntax...... just that I type fast. The above okay for you, I trust? ;)

Skin Biotherapeutics. Trials coming through in 2021 that look positive and a small (but regular revenue). I bought in at 17p a couple of days ago with my profits. Now 22.5. Up about 30%. Lets see how this "similar" company does - seems that it's SP is increasing on positive feeling. In contrast to FUM. The market (especially AIM) may not be entirely rationale... but there is some logic.....

I quite like this board. It's small enough to have a "community" feel and there is diversity if opinion. There are one or two who I think are not giving honest opinions, just rampers that dont believe what they say. But I guess they may think I'm a deramper who doesnt believe what I say.

Question for the regulars. Would this be an okay place to talk about our investment portfolios? I have decided not to invest more in FUM until (I believe) we get a share offering in March time. So, having already spent by Autumn, my 2020 ISA allowance (and having made some very decent gains this year), i decided to invest fairly heavily with my profits with a biotech company. I wont name them unless people generally feel that we can chat about 2021 investment plans in this forum, as a side issue to the main one of FUM.

Thoughts?

Dactions. I post about FUM on a FUM BB. And ask questions and give opinions. Isnt that the idea? Or shall we talk about Dancing on Ice 2021? I cant control how Ananda responds.

The average SP for FUM for 2020 is about 14.5p. So the SP is about average. It was about 30 in Q4 2019 but then crashed to 9p after the "failure of the Phase 111 trial". It then went to about average based on the hopeful medical device route, where FUM scrapped development of the active ingredient product (MED2005) and now just hopefully launching the device (the solvent that transported the active ingredient of MED2005 across the skin). This is known as med3000. This is fact. FUM opinion is that this inactive solvent (Med3000) by evaporation stimulates the nerves in the pen1s after manual application and causes an erection. Ok, could be true.

Ok. The question is this. Why, if EMA approval is "days away" according to Ananda (or in 2021 - according to FUM), why is it still at the 2020 average SP of 14.5p? (which is historically, looking back at the SP history, actually very low). After coming back from 7p (or so - nearly an all time low after the Phase III failure in December 2019) and is now half the price (14p vs 30p) before the "failure" of the Phase III trial? Shouldn't it rationally, be now between 20 and 30p (mean 25p)? It is actually near, or at, a very low average SP for FUM, when according to them, approval in US and EMA is in 2021. That says to me, the market does not believe FUM.

On top of that, still no news on any partners, or EMA feedback on the FUM submission, and FUM runs out of money in May 2021. So..... When do the FUM believers believe will "the month" - its been every month since about July 2020. Will Feb 2021 now be "the month"? If not, please tell us when? As i think many people here are thinking its very early 2021. Please tell us buconic, ananda :)